Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial.

ABSTRACT:

Background

Homeopathic drug proving is a basic concept in homeopathy. This study aimed to record symptoms produced by a homeopathic drug compared with placebo.

Methods

This multicentre, randomised, double-blind, placebo-controlled phase 1 trial consisted of a 7-day run-in period, a 5-day intervention period and a 16-day post-intervention observation period. Subjects, investigators and statisticians were blinded for intervention groups and identity of the homeopathic drug. Subjects in the intervention group received Okoubaka aubrevillei (potency C12) and subjects in the placebo group received the optically identical sucrose globules. Dosage in both groups was five globules taken five times per day over a maximum period of 5 days. Subjects documented the symptoms they experien

SUBMITTER: Teut M 

PROVIDER: S-EPMC3652761 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature